0001209191-19-059186.txt : 20191204
0001209191-19-059186.hdr.sgml : 20191204
20191204200017
ACCESSION NUMBER: 0001209191-19-059186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191202
FILED AS OF DATE: 20191204
DATE AS OF CHANGE: 20191204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Auerbach Michael
CENTRAL INDEX KEY: 0001746080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 191269269
MAIL ADDRESS:
STREET 1: 158 HESTER STREET
STREET 2: APT 7F
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
BUSINESS PHONE: 2064329325
MAIL ADDRESS:
STREET 1: 1100 MAUGHAN ROAD
CITY: NANAIMO
STATE: A1
ZIP: V9X 1J2
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-02
0
0001731348
Tilray, Inc.
TLRY
0001746080
Auerbach Michael
1100 MAUGHAN ROAD
NANAIMO
A1
V9X IJ2
BRITISH COLUMBIA, CANADA
1
0
0
0
Class 2 Common Stock
2019-12-02
4
M
0
18750
7.76
A
31875
D
Class 2 Common Stock
2019-12-02
4
S
0
31875
19.0508
D
0
D
Class 2 Common Stock
2019-12-02
4
S
0
7537
19.0508
D
42928
I
By M3 Ein Sof LLC
Class 2 Common Stock
2019-12-02
4
S
0
900
19.8144
D
42028
I
By M3 Ein Sof LLC
Stock Option (Right to Buy)
7.76
2019-12-02
4
M
0
18750
0.00
D
2028-05-20
Class 2 Common STock
18750
31250
D
The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.75 to $19.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.75 to $19.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 4 to this Form 4.
The shares vest at the rate of 25% of the shares on the twelve (12) month anniversary of April 1, 2018 (the "Vest Date"), and the remaining shares will vest quarterly thereafter at the rate of 6.25% of the total number of shares on each quarterly anniversary of the Vesting Date thereafter for so long as the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan), such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Date.
/s/ Yuri Weigel, Attorney-in-fact
2019-12-04